Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

July 12, 2023

Study Completion Date

July 12, 2023

Conditions
Chronic PainOpioid Use Disorder
Interventions
DEVICE

RelieVRx

The virtual reality device that will be piloted is called RelieVRx, which incorporates evidence-based principles of cognitive behavioral therapy, mindfulness, and pain neuroscience education into an immersive and enhanced biofeedback experience. RelieVRx includes breathing training and relaxation response exercises that activate the parasympathetic nervous system. RelieVRx was designed for at-home use and comes with a sequence of daily immersive experiences.

DEVICE

Sham VR

The sham VR control is a non-immersive set of 56 daily virtual experiences, tuned to the length of the RelieVRx.

Trial Locations (1)

10451

Melrose Clinic, The Bronx

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Albert Einstein College of Medicine

OTHER